Beta Bionics, Inc. (BBNX) Change in Accured Expenses (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Change in Accured Expenses data on file, last reported at -$5.2 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 1.06% year-over-year to -$5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 316.48% YoY) and the FY2025 annual result came in at $7.4 million, up 8.57% from the prior year.
• Change in Accured Expenses slipped to -$5.2 million in Q1 2026 per BBNX's latest filing, from $5.9 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $5.9 million in Q4 2025, with the low at -$5.3 million in Q1 2025.
• Average Change in Accured Expenses over 3 years is $1.0 million, with a median of $2.3 million recorded in 2024.
• The widest YoY moves for Change in Accured Expenses: up 242.92% in 2025, down 2182.68% in 2025.
• Beta Bionics' Change in Accured Expenses stood at $3.6 million in 2024, then jumped by 64.16% to $5.9 million in 2025, then sank by 189.04% to -$5.2 million in 2026.
• Business Quant data shows BBNX's Change in Accured Expenses at -$5.2 million in Q1 2026, $5.9 million in Q4 2025, and $4.1 million in Q3 2025.